The growth of the protein assays market can be attributed to the increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research.
Based on the analysis of strategic developments undertaken by market players between 2014 and 2017, the key strategy followed by most companies in the market is expansions and agreements, partnerships, and collaborations. Some of the leading players that adopted this strategy include Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), Abcam plc. (U.S.), and PerkinElmer Inc. (U.S.).
Download the PDF Brochure for More Details@ http://bit.ly/2S7IZnX
Thermo Fisher Scientific was leading player in the protein assay products market in 2016. The company focuses on organic and inorganic strategies in order to strengthen its position in the market. In 2015, the company acquired Alfa Aesar (U.S.), and in 2014 acquired Life Technology Corporation (U.S.) these acquisitions helped the company strengthen its protein assays product portfolio. In 2017, the company acquired Core Informatics (U.S.) and in 2016 acquired Affymetrix (U.S.) in order to enhance its share in the market. In 2016, the company expanded its clinical trials support in Japan. In 2015, the company opened its new clinical services facility in Singapore. These expansions helped the company to amplify its geographic reach.
Merck KGaA was another leading player in the protein assay products market in 2016. It focuses mainly on collaborations, acquisitions, and expansions to strengthen its position in the market. In November 2015, the company acquired Sigma Aldrich (U.S.). This acquisition helped it to increase its product portfolio and its geographic presence. The company also focuses on expansions to strengthen its market share. In September 2016, the company expanded its R&D facility in China. This helped the company to increase its protein assays product portfolio. In March 2015, the company collaborated with Illumina (U.S.). This collaboration helped the company to develop assays used in clinical trials.
Geographically, the protein assays market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growth in pharmaceutical and biotechnology industries, strong trend of R&D in the life sciences industry, increase in private-public partnerships for drug development, and the presence of a large number of major market players in this region are further driving the growth of this market.
Key players operating in the protein assays market include Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), Abcam plc (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
Target Audience for this Report:
- Protein assay manufacturers and vendors
- Distributors of protein assays
- Various research and consulting companies
- Associations related to pharmaceutical and biotechnological research
Related Reports:
Protein Assays Market by Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab) – Global Forecasts to 2022
